ASP6294
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ASP6294, covering 2017-01-10 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis [Phase 2]